Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alfred J. Remillard"'
Autor:
Habiba Elshorbagy, Joshua Nurkowski, Alfred J. Remillard, Katelyn Halpape, Darcy A. Lamb, Eric Landry, Karen Jensen, Derek Jorgenson
Publikováno v:
Innovations in Pharmacy
INNOVATIONS in Pharmacy, Vol 11, Iss 3 (2020)
INNOVATIONS in Pharmacy, Vol 11, Iss 3 (2020)
Background: Chronic insomnia is a common medical condition that negatively impacts quality of life and daytime function. Access to the first-line treatment for insomnia, cognitive behavioural therapy (CBT-i), is limited. Pharmacists are well position
Autor:
Anne Champagne, Dean T. Eurich, Jeff Taylor, David Tran, William Semchuk, Alfred J. Remillard, Yvonne Shevchuk, Charity Evans, Derek Jorgenson, Kerry Mansell, David F. Blackburn
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36:1055-1064
tudy Objective To test a brief intervention for preventing statin nonadherence among community pharmacy patrons. Design Prospective, cluster-randomized, controlled trial (the Community Pharmacists Assisting in Total Cardiovascular Health [CPATCH] tri
Autor:
Alfred J. Remillard, David F. Blackburn, Yvonne Shevchuk, Charity Evans, Dean T. Eurich, Xinya Lu
Publikováno v:
American Journal of Hypertension. 26:180-190
BACKGROUND High adherence to angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reported in observational studies has frequently been attributed to improved tolerability. However, these agents are also relativel
Publikováno v:
Journal of Interprofessional Care. 24:274-284
Pharmacists have been encouraged to enhance their role on primary healthcare teams; but, the profession has yet to be involved to the degree in which a substantial impact can be made. The objective of this study was to provide guidance on how to inte
Autor:
David F, Blackburn, David, Tran, Alex, Crawley, Sarah, Lynds, Anne, Champagne, Lauren, Bresee, Alfred J, Remillard
Publikováno v:
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique. 21(1)
Drug benefit providers can decrease prescribing of specific medications through prior authorization policies. In Saskatchewan, certain second generation antipsychotics (SGAs) are recognized as first-line agents to manage schizophrenia; but, require p
Publikováno v:
Annals of Pharmacotherapy. 34:585-592
OBJECTIVE: To determine the impact of a drug information service on patient outcomes. DESIGN: Prospective evaluation of patient-specific drug information requests. SETTING: Healthcare professional and consumer drug information service located at a co
Autor:
Alfred J. Remillard
Publikováno v:
Pharmacoepidemiology and Drug Safety. 5:155-164
The elderly are high consumers of both prescription and over-the-counter medications. As a result of age-related changes in drug pharmacokinetics and pharmacodynamics, they experience twice the number of adverse effects than in the general population
Publikováno v:
American journal of hypertension. 25(2)
Background Medication nonadherence is a barrier to successfully managing hypertension, but little is known about the contribution that immediate discontinuations have on antihypertensive (AHT) nonadherence. The purpose of this study was to determine
Autor:
Charity Evans, Jeff Taylor, David F. Blackburn, Dean T. Eurich, Alfred J. Remillard, Yvonne Shevchuk
Publikováno v:
Trials, Vol 11, Iss 1, p 76 (2010)
Trials
Trials
Background Traditional randomized controlled trials are considered the gold standard for evaluating the efficacy of a treatment. However, in adherence research, limitations to this study design exist, especially when evaluating real-world applicabili